News
Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...
Bristol Myers Squibb leapt into the drug industry’s most intense new rivalry on Monday, signing a deal to potentially spend ...
As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to ...
Big Pharma is investing heavily in AI to slash development timelines and foster innovation. But instead of strengthening future relationships with the biotech world, the investment may position ...
That is essentially the idea behind Roivant ROIV-0.64%decrease; red down pointing triangle, a biotech company with a handful of drugs it got from pharma’s dustbin. Roivant was founded by the ...
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news. Investors clearly took the latter more to heart ...
To get caught up, we’re rounding up all the hires, appointments, and promotions we heard about in the pharma and biotech world in the months of May and June. Stay tuned for more round-ups ...
Bloomberg Intelligence’s team of experienced biotech, pharma, policy and litigation analysts author exclusive, data-driven research that can help you pinpoint long-term market opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results